Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei.

Abstract

An example for the bidirectional exchange of activating signals between a pathogen and immunocompetent cells in the host is presented. Trypanosoma brucei, which include subspecies that cause African sleeping sickness, secrete a molecule that triggers lymphocytes to produce interferon (IFN)-gamma. We now report that proliferation of T. brucei is stimulated in axenic cultures by IFN-gamma. The growth-enhancing effect on the pathogen is inhibited by anti-IFN-gamma receptor (R) antibodies and does not occur after exposure to other cytokines, i.e. IFN-alpha, IFN-beta and tumor necrosis factor (TNF)-alpha. While rodent-pathogenic T. brucei strains are stimulated by rat IFN-gamma, human pathogenic strains are more potently stimulated by human IFN-gamma. Rat and human IFN-gamma can partially block each others effects. Mice with disrupted IFN-gamma genes have reduced parasitemia and prolonged survival, while the outcome is reversed in mice that lack the IFN-gamma R gene.